Dr Brenda Jean Berberian, MD | |
5530 Wisconsin Ave, Suite 1443, Chevy Chase, MD 20815-4320 | |
(301) 656-7660 | |
(301) 656-0634 |
Full Name | Dr Brenda Jean Berberian |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 5530 Wisconsin Ave, Chevy Chase, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063490027 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | D0029682 (Maryland) | Primary |
207NS0135X | Dermatology - Procedural Dermatology | 0029682 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Brenda Jean Berberian, MD 5530 Wisconsin Ave, Suite 1443, Chevy Chase, MD 20815-4320 Ph: (301) 656-7660 | Dr Brenda Jean Berberian, MD 5530 Wisconsin Ave, Suite 1443, Chevy Chase, MD 20815-4320 Ph: (301) 656-7660 |
News Archive
Male breast cancer patients were found to have a high prevalence of cardiovascular conditions, in a small study of this rare patient population presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient Virtual course.
Schering-Plough Corporation has announced that it has responded to the U.S. Food and Drug Administration (FDA) complete response letter for SAPHRIS (asenapine) sublingual tablets, which was received in January 2009.
According to a Canadian health official test results on wild migratory ducks across Canada have not shown any link to the deadly Asian strain of the bird flu virus that has spread from Southeast Asia to Europe.
Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, today announced operational, clinical and financial results for the year ended December 31, 2014.
The German Institute for Quality and Efficiency in Health Care assessed the added benefit of ticagrelor for patients with acute coronary syndrome already in 2011 in its very first dossier assessment, just after the Act on the Reform of the Market for Medicinal Products had come into force.
› Verified 1 days ago
Dr. Panteha Tamjidi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave, Suite 1045, Chevy Chase, MD 20815 Phone: 301-652-4828 Fax: 301-652-2070 | |
Etsubdenk Mezemir Ajebo, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5530 Wisconsin Ave Ste 730, Chevy Chase, MD 20815 Phone: 301-951-2400 | |
Dr. Geeta Mohla Shah, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5471 Wisconsin Ave Ste 200, Chevy Chase, MD 20815 Phone: 301-798-9699 Fax: 240-802-2993 | |
Dr. Min Deng, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave Ste 730, Chevy Chase, MD 20815 Phone: 301-951-2400 Fax: 301-951-2401 | |
Allison R Larson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave Ste 730, Chevy Chase, MD 20815 Phone: 301-951-2400 Fax: 301-951-2401 | |
Peter C Morse, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5425 Wisconsin Ave, Suite 702, Chevy Chase, MD 20815 Phone: 301-634-1411 Fax: 301-634-1425 |